TARGET
saveBRAF
Serine/threonine kinase frequently mutated in melanoma.
also known as: b-raf, braf v600e
🐶 often sniffed alongside
top 2drugs
0
catalysts
0
news
28
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Labcorp nabs FDA green light for BRAF melanoma diagnosticfiercebiotech · 2mo ago
- Replimune to ride wave of physician support to launch advanced melanoma therapybiospace · 2mo ago
- Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapiesfiercebiotech · 2mo ago
- STAT+: Does Revolution Medicines’ pancreatic cancer drug have even greater potential?stat · 4mo ago
- Dr Sznol on the Nuances of Recommending Neoadjuvant Therapy in Metastatic Melanomaonclive · 5mo ago
- Biomarker-Directed Therapies Move the GI Oncology Paradigm Beyond a One-Size-Fits-All Approach: With Michael J. Pishvaian, MD, PhDonclive · 5mo ago
- Dr Sznol on Optimal Treatment Sequencing in Melanomaonclive · 5mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that